We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

IBA Announces Expansion of Collaboration with MorphoSys AbD Serotec

The original research license agreement dating back to the year 2000 has now been complemented with a second license agreement.
News

Waters Corporation and Advion BioSciences Announce Collaboration

Firms intend to combine products and offer life scientists enhanced capabilities.
News

Fusion Antibodies Announces Appointment of New CEO

The appointment of Dr Douglas further strengthens the board at Fusion Antibodies.
News

ACE Biosciences Appoints Dr Roberto Machuca as Operations Manager

Company appoints Dr Roberto to scale up manufacture of Travellers’ Diarrhoea vaccine.
News

Akorn and Serum Institute of India Announce Development and Distribution Agreement for Rabies Monoclonal Antibody

Akorn receives exclusive marketing and distribution rights to North, Central, and South America.
News

Ablynx Enters into a Research and License Agreement with Wyeth

Ablynx has granted Wyeth exclusive worldwide rights to Nanobodies® targeting the clinically validated target TNF- a.
News

Cambridge Antibody Technology to Expand Operations in Cambridge, UK

Unit GP15 will provide CAT with an additional 92,000 square feet of laboratory and associated open-plan office space.
News

Medarex and PacMab Announce Therapeutic Antibody Co-Development Agreement

Companies intend to use Medarex's UltiMAb Human Antibody Development System® to generate fully human antibodies.
News

Lpath Collaborates with Sapient Discovery

Companies collaborate to characterize favorable interactions of Lpath's Anti-S1P therapeutic antibody with its target.
News

Genzyme Launches Cystic Fibrosis Gene Sequencing Test

CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.
Advertisement